CRAIG WILLIAM S 4
4 · CADENCE PHARMACEUTICALS INC · Filed Jul 16, 2009
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common stock
2009-07-15$0.40/sh+2,500$1,000→ 4,500 total - Sale
Common stock
2009-07-15$11.00/sh−2,500$27,500→ 2,000 total - Exercise/Conversion
Stock option (right to buy)
2009-07-15−2,500→ 80,000 totalExercise: $0.40From: 2005-02-16Exp: 2015-02-15→ common stock (2,500 underlying)
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2009.
- [F2]Not applicable to this transaction.